| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.078 | 0.08 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.09 |